Advantage Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $12K | Hold |
45
| – | – | 0.01% | 619 |
|
|
2019
Q2 | $14K | Sell |
45
-22
| -33% | -$6.84K | 0.01% | 607 |
|
|
2019
Q1 | $28K | Sell |
67
-5
| -7% | -$2.09K | 0.02% | 456 |
|
|
2018
Q4 | $27K | Buy |
72
+25
| +53% | +$9.38K | 0.02% | 460 |
|
|
2018
Q3 | $19K | Buy |
47
+25
| +114% | +$10.1K | 0.01% | 586 |
|
|
2018
Q2 | $8K | Sell |
22
-6
| -21% | -$2.18K | 0.01% | 690 |
|
|
2018
Q1 | $10K | Buy |
28
+6
| +27% | +$2.14K | ﹤0.01% | 681 |
|
|
2017
Q4 | $8K | Hold |
22
| – | – | ﹤0.01% | 738 |
|
|
2017
Q3 | $10K | Hold |
22
| – | – | ﹤0.01% | 693 |
|
|
2017
Q2 | $11K | Hold |
22
| – | – | ﹤0.01% | 688 |
|
|
2017
Q1 | $9K | Hold |
22
| – | – | ﹤0.01% | 706 |
|
|
2016
Q4 | $8K | Hold |
22
| – | – | ﹤0.01% | 680 |
|
|
2016
Q3 | $9K | Sell |
22
-127
| -85% | -$52K | ﹤0.01% | 641 |
|
|
2016
Q2 | $52K | Buy |
149
+9
| +6% | +$3.14K | 0.02% | 339 |
|
|
2016
Q1 | $50K | Buy |
140
+118
| +536% | +$42.1K | 0.02% | 332 |
|
|
2015
Q4 | $12K | Hold |
22
| – | – | 0.01% | 539 |
|
|
2015
Q3 | $10K | Hold |
22
| – | – | 0.01% | 542 |
|
|
2015
Q2 | $11K | Hold |
22
| – | – | 0.01% | 576 |
|
|
2015
Q1 | $10K | Hold |
22
| – | – | 0.01% | 590 |
|
|
2014
Q4 | $9K | Buy |
+22
| New | +$9K | 0.01% | 542 |
|